A citation-based method for searching scientific literature

Calvin Ly, Alexandra C Greb, Maxemiliano V Vargas, Whitney C Duim, Ana Cristina G Grodzki, Pamela J Lein, David E Olson. ACS Pharmacol Transl Sci 2020
Times Cited: 24







List of co-cited articles
441 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
304
87


Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A Davoudian, Neil K Savalia, Kristina Delagarza, Alex C Kwan. Neuron 2021
70
66

A non-hallucinogenic psychedelic analogue with therapeutic potential.
Lindsay P Cameron, Robert J Tombari, Ju Lu, Alexander J Pell, Zefan Q Hurley, Yann Ehinger, Maxemiliano V Vargas, Matthew N McCarroll, Jack C Taylor, Douglas Myers-Turnbull,[...]. Nature 2021
82
62

The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects.
David B Yaden, Roland R Griffiths. ACS Pharmacol Transl Sci 2020
83
54

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
628
54

Psychedelics.
David E Nichols. Pharmacol Rev 2016
528
54

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
254
50


Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
Natalie Hesselgrave, Timothy A Troppoli, Andreas B Wulff, Anthony B Cole, Scott M Thompson. Proc Natl Acad Sci U S A 2021
61
50

A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.
Neil K Savalia, Ling-Xiao Shao, Alex C Kwan. Trends Neurosci 2021
29
50

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
257
45

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
524
45

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
517
45

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.
Franz X Vollenweider, Katrin H Preller. Nat Rev Neurosci 2020
110
45

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
Javier González-Maeso, Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou,[...]. Neuron 2007
492
45

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
Lindsay P Cameron, Charlie J Benson, Brian C DeFelice, Oliver Fiehn, David E Olson. ACS Chem Neurosci 2019
62
41

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Martin K Madsen, Patrick M Fisher, Daniel Burmester, Agnete Dyssegaard, Dea S Stenbæk, Sara Kristiansen, Sys S Johansen, Sczabolz Lehel, Kristian Linnet, Claus Svarer,[...]. Neuropsychopharmacology 2019
126
41

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.
Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nídia Fernandez Ros, Brice Ozenne, Hanne Demant Hansen, Gitte Moos Knudsen. Int J Mol Sci 2021
44
41

Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies.
Lee E Dunlap, Arya Azinfar, Calvin Ly, Lindsay P Cameron, Jayashri Viswanathan, Robert J Tombari, Douglas Myers-Turnbull, Jack C Taylor, Ana Cristina Grodzki, Pamela J Lein,[...]. J Med Chem 2020
26
37

Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.
Briony J Catlow, Shijie Song, Daniel A Paredes, Cheryl L Kirstein, Juan Sanchez-Ramos. Exp Brain Res 2013
110
37


Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling,[...]. Psychopharmacology (Berl) 2018
287
37

Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
254
37

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi. Pharmacol Rev 2021
50
37


An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress.
Ju Lu, Michelle Tjia, Brian Mullen, Bing Cao, Kacper Lukasiewicz, Sajita Shah-Morales, Sydney Weiser, Lindsay P Cameron, David E Olson, Lu Chen,[...]. Mol Psychiatry 2021
20
45

Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.
Meghan Hibicke, Alexus N Landry, Hannah M Kramer, Zoe K Talman, Charles D Nichols. ACS Chem Neurosci 2020
56
37

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.
Kuglae Kim, Tao Che, Ouliana Panova, Jeffrey F DiBerto, Jiankun Lyu, Brian E Krumm, Daniel Wacker, Michael J Robertson, Alpay B Seven, David E Nichols,[...]. Cell 2020
132
33

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
540
33

Psychedelic-inspired drug discovery using an engineered biosensor.
Chunyang Dong, Calvin Ly, Lee E Dunlap, Maxemiliano V Vargas, Junqing Sun, In-Wook Hwang, Arya Azinfar, Won Chan Oh, William C Wetsel, David E Olson,[...]. Cell 2021
39
33

Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex.
Victoria Phoumthipphavong, Florent Barthas, Samantha Hassett, Alex C Kwan. eNeuro 2016
65
33

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
33

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt,[...]. Neuropsychopharmacology 2021
66
33

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.
Nadia R P W Hutten, Natasha L Mason, Patrick C Dolder, Eef L Theunissen, Friederike Holze, Matthias E Liechti, Nimmy Varghese, Anne Eckert, Amanda Feilding, Johannes G Ramaekers,[...]. ACS Pharmacol Transl Sci 2020
38
29

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.
Lindsay P Cameron, Charlie J Benson, Lee E Dunlap, David E Olson. ACS Chem Neurosci 2018
66
29



Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.
Bashkim Kadriu, Maximillian Greenwald, Ioline D Henter, Jessica R Gilbert, Christoph Kraus, Lawrence T Park, Carlos A Zarate. Int J Neuropsychopharmacol 2021
31
29

Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling.
Kelly A Jones, Deepak P Srivastava, John A Allen, Ryan T Strachan, Bryan L Roth, Peter Penzes. Proc Natl Acad Sci U S A 2009
126
29

Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Frederick S Barrett, Manoj K Doss, Nathan D Sepeda, James J Pekar, Roland R Griffiths. Sci Rep 2020
87
29

Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.
Mario de la Fuente Revenga, Bohan Zhu, Christopher A Guevara, Lynette B Naler, Justin M Saunders, Zirui Zhou, Rudy Toneatti, Salvador Sierra, Jennifer T Wolstenholme, Patrick M Beardsley,[...]. Cell Rep 2021
34
29

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
Lily R Aleksandrova, Anthony G Phillips. Trends Pharmacol Sci 2021
24
29

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
882
25

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
421
25

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
25

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
Rafael G Dos Santos, Flávia L Osório, José Alexandre S Crippa, Jordi Riba, Antônio W Zuardi, Jaime E C Hallak. Ther Adv Psychopharmacol 2016
128
25

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.
Raíssa Nóbrega de Almeida, Ana Cecília de Menezes Galvão, Flávia Santos da Silva, Erick Allan Dos Santos Silva, Fernanda Palhano-Fontes, João Paulo Maia-de-Oliveira, Lobão-Soares Barros de Araújo, Bruno Lobão-Soares, Nicole Leite Galvão-Coelho. Front Psychol 2019
66
25

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
776
25

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot'alora G, Wael Garas, Casey Paleos, Ingmar Gorman,[...]. Nat Med 2021
165
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.